General MedicationsORALGeneric

DEXEDRINE

DEXTROAMPHETAMINE SULFATE

Standard Dose

5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview DEXEDRINE is listed in Drugs@FDA under application 083902 (ANDA).

Marketing status: Discontinued Active ingredient DEXTROAMPHETAMINE SULFATE Form and strength ELIXIR;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2000-11-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEXEDRINE is listed in Drugs@FDA under application 083902 (ANDA). Marketing status: Discontinued Active ingredient DEXTROAMPHETAMINE SULFATE Form and strength ELIXIR;ORAL - 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2000-11-28 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.